Cambiar Investors LLC Sells 5,905 Shares of Molina Healthcare, Inc $MOH

Cambiar Investors LLC decreased its stake in Molina Healthcare, Inc (NYSE:MOH) by 19.7% in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 24,036 shares of the company’s stock after selling 5,905 shares during the quarter. Cambiar Investors LLC’s holdings in Molina Healthcare were worth $7,160,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also bought and sold shares of the stock. Price T Rowe Associates Inc. MD increased its position in Molina Healthcare by 46.4% in the first quarter. Price T Rowe Associates Inc. MD now owns 3,838,043 shares of the company’s stock worth $1,264,214,000 after buying an additional 1,216,903 shares in the last quarter. T. Rowe Price Investment Management Inc. lifted its holdings in Molina Healthcare by 8.6% during the first quarter. T. Rowe Price Investment Management Inc. now owns 1,487,896 shares of the company’s stock valued at $490,099,000 after purchasing an additional 117,796 shares in the last quarter. AQR Capital Management LLC lifted its holdings in Molina Healthcare by 42.7% during the first quarter. AQR Capital Management LLC now owns 884,958 shares of the company’s stock valued at $288,125,000 after purchasing an additional 264,664 shares in the last quarter. Durable Capital Partners LP lifted its holdings in Molina Healthcare by 13.1% during the first quarter. Durable Capital Partners LP now owns 541,605 shares of the company’s stock valued at $178,399,000 after purchasing an additional 62,899 shares in the last quarter. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its holdings in Molina Healthcare by 1.5% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 465,672 shares of the company’s stock valued at $153,388,000 after purchasing an additional 7,021 shares in the last quarter. Hedge funds and other institutional investors own 98.50% of the company’s stock.

Insider Buying and Selling

In related news, Director Ronna Romney sold 700 shares of the business’s stock in a transaction on Wednesday, August 6th. The shares were sold at an average price of $153.74, for a total value of $107,618.00. Following the sale, the director owned 17,131 shares in the company, valued at approximately $2,633,719.94. The trade was a 3.93% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, COO James Woys purchased 10,000 shares of Molina Healthcare stock in a transaction that occurred on Monday, August 4th. The stock was acquired at an average price of $155.94 per share, for a total transaction of $1,559,400.00. Following the transaction, the chief operating officer directly owned 74,331 shares of the company’s stock, valued at $11,591,176.14. The trade was a 15.54% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. 1.10% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

Several equities analysts have weighed in on MOH shares. Weiss Ratings reaffirmed a “sell (d+)” rating on shares of Molina Healthcare in a report on Wednesday, October 8th. Truist Financial set a $175.00 price target on shares of Molina Healthcare in a report on Friday, October 24th. Mizuho lowered their price target on shares of Molina Healthcare from $400.00 to $330.00 and set an “outperform” rating on the stock in a report on Friday, July 11th. Sanford C. Bernstein lowered their price target on shares of Molina Healthcare from $284.00 to $220.00 and set an “outperform” rating on the stock in a report on Friday, September 5th. Finally, Deutsche Bank Aktiengesellschaft set a $165.00 price target on shares of Molina Healthcare in a report on Friday, October 24th. Three analysts have rated the stock with a Buy rating, eleven have given a Hold rating and two have issued a Sell rating to the stock. Based on data from MarketBeat, Molina Healthcare currently has an average rating of “Hold” and a consensus target price of $203.64.

Molina Healthcare Trading Up 1.2%

Molina Healthcare stock opened at $152.98 on Friday. The stock has a market cap of $8.29 billion, a P/E ratio of 9.47 and a beta of 0.55. The company has a debt-to-equity ratio of 0.92, a current ratio of 1.68 and a quick ratio of 1.68. Molina Healthcare, Inc has a 1 year low of $147.75 and a 1 year high of $359.97. The firm’s 50 day moving average price is $182.71 and its 200-day moving average price is $231.52.

Molina Healthcare (NYSE:MOH) last announced its quarterly earnings results on Wednesday, October 22nd. The company reported $1.84 EPS for the quarter, missing analysts’ consensus estimates of $3.97 by ($2.13). Molina Healthcare had a net margin of 1.98% and a return on equity of 22.95%. The firm had revenue of $11.48 billion for the quarter, compared to the consensus estimate of $10.99 billion. During the same period in the previous year, the company posted $6.01 earnings per share. Molina Healthcare’s quarterly revenue was up 11.0% on a year-over-year basis. Molina Healthcare has set its FY 2025 guidance at 14.000-14.000 EPS. On average, equities analysts predict that Molina Healthcare, Inc will post 24.4 earnings per share for the current fiscal year.

About Molina Healthcare

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.